This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives
The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical company that could benefit from increased purchases of over-the-counter contraceptives. The Perrigo Analyst: Raymond James analyst Elliot Wilbur has an Outperform rating on Perrigo Company (NYSE: PRGO ). The Analyst Takeaways: Wilbur cites Perrigo as a possible benefactor of the Supreme Court ruling thanks to a switch to over-the-counter initiatives the company has made. Related Link: 3 Women''s Health Stocks Are Soaring Following Roe V. Wade Ruling “PRGO should be at the forefront of any discussions regarding potential financial beneficiaries from changes in the reproductive health landscape that will likely emerge from the ruling,” Wilbur said. Perrigo acquired HRA Pharma in … Full story available on Benzinga.com
This $5B Pharmaceutical Could Benefit From Over-The-Counter Contraceptives And Plan B Alternatives
The ruling by the U.S. Supreme Court to overturn Roe v. Wade and leave the decision of abortion to the states has been a big topic over the last few days. An analyst singles out a pharmaceutical company that could benefit from increased purchases of over-the-counter contraceptives. The Perrigo Analyst: Raymond James analyst Elliot Wilbur has an Outperform rating on Perrigo Company (NYSE: PRGO ). The Analyst Takeaways: Wilbur cites Perrigo as a possible benefactor of the Supreme Court ruling thanks to a switch to over-the-counter initiatives the company has made. Related Link: 3 Women''s Health Stocks Are Soaring Following Roe V. Wade Ruling “PRGO should be at the forefront of any discussions regarding potential financial beneficiaries from changes in the reproductive health landscape that will likely emerge from the ruling,” Wilbur said. Perrigo acquired HRA Pharma in … Full story available on Benzinga.com